During an education session at the SupplyExpo tradeshow, held in conjunction with Natural Products Expo West, OVOS Natural Health will present VIVIMIND, a new dietary supplement that protects memory function, backed by 15 years of research and clinical testing in more than 2,000 individuals. Denis Garceau, Ph.D., OVOS Natural Health’s Chief Science Officer will present “VIVIMIND: A New Generation of Memory Protection” on Friday, March 6, from 9:30 – 10:30 a.m. in room 207C at the Anaheim Convention Center. (source: npicenter.com)
Although Vivimind as a treatment for the memory brain has not yet been approved by regulatory bodies in the US, OVOS Natural Health is quite confident that it will receive such approval in due course, opening up their over the counter nutraceutical to the massive US market. Of course the idea that Vivimind could be marketed to both young and old lends itself to the idea that the potential market would truly be very large. Some more details on how OVOS plans to handle this education opportunity and their outlook on their company's odds of getting approval in the near future:
During his presentation, Dr. Garceau will highlight the research supporting VIVIMINDs neuroprotective effects which include sustaining brain cell health, protecting brain structures associated with memory and learning, maintaining verbal skills and comprehension ability, and supporting planning and execution skills. VIVIMIND, based on the naturally occurring ingredient, homotaurine (found in seaweed) is supported by a comprehensive research portfolio validating its safety, tolerability and efficacy profiles in protecting memory function: “VIVIMIND has received scientific support and has been embraced by consumers in the Canadian market since its launch in September 2008,” noted Jim Stitley, General Manager, U.S. Commercial Operations for OVOS Natural Health. “We are pleased to inform Nutracon, Expo West and SupplyExpo attendees about this new cognitive dietary supplement VIVIMIND that will be launched soon in the U.S., pending approval.”
(source: npicenter.com)In order to build awareness, OVOS Natural Health will be showcasing VIVIMIND™ at booth #2696 on the Natural Products Expo West show floor and will have a tabletop with product literature at Nutracon, to be held March 4 – 5 at the Anaheim Hilton. The company is also a Gold sponsor of the SupplyExpo show.
Here is some more detailed information on Dr. Denis Garceau, the current Director of OVOS Natural Health's product development program:
Dr. Denis Garceau directs OVOS Natural Health’s product development program from toxicology to clinical evaluation through regulatory compliance of new products. He holds a Ph.D. in Pharmacology from the Université de Montréal, and is currently a guest lecturer for the faculty of Pharmacy of Université de Montréal and Université Laval. Dr. Garceau is also Senior Vice President, Drug Development at BELLUS Health Inc., and is a member of the board of directors for Virochem Pharma Inc. and BELLUS Health (Innodia) Inc.
